Seminars in Nuclear Medicine
Volume 34, Issue 2 , Pages 154-156 , April 2004

Diffuse increased uptake on bone scan: super scan

  • Mehrzad Cohen Pour

      Affiliations

    • Institute of Nuclear Medicine, Zerifin, Israel
    • ,
  • Yehudit Simon-Corat

      Affiliations

    • Department of Radiology, Assaf Harofeh Medical Center, Zerifin 70300, Israel (affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Israel)
    • ,
  • Tifha Horne

      Affiliations

    • Institute of Nuclear Medicine, Zerifin, Israel
    • Corresponding Author InformationAddress reprint requests to Tifha Horne, MD, Institute of Nuclear Medicine, Assaf Harofeh Medical Center, Zerifin 70300, Israel

References 

  1. Podoloff DA, Kim EE. “Sub”-super scan—manifestation of bone marrow metastases?. Clin Nucl Med. 1989;14:597–602
  2. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res. 1988;48:6876–6881
  3. Frankel RS, Johnson KW, Mabry JJ, et al.  “Normal” bone radionuclide image with diffuse skeletal lymphoma (A case report). Radiology. 1974;111:365–366
  4. Thrumpkaew AK, Henkin R, Quinn JL. A false negative bone scan and disseminated metastasis disease. Radiology. 1974;113:383–386
  5. Sy WM, Patel D, Faunce H. Significance of absent or faint kidney sign on bone scan. J Nucl Med. 1975;16:454–456
  6. Mitlack BH, Daly M, Potts JT, et al.  Asymptomatic primary hyperparathyroidism. J Bone Miner Res. 1991;6(suppl 2):S103–S110
  7. Campeau RJ, Bellah RD, Varma DGK. Pathologic fractures in a patient with renal osteodystrophy (Failure of early detection on bone scans). Clin Nucl Med. 1987;12:510–513
  8. Rosenthal L, Kaye M. Observation on the mechanism of Tc 99-m labeled phosphate complex uptake in metabolic bone disease. Semin Nucl Med. 1976;6:59–67
  9. Nordin BEC, Horsman A, Arnon J. Diagnostic procedure. In:  Nordin BEC editors. Calcium, phosphate and magnesium metabolism. Edinburgh: Churchill Livingstone; 1975;p. 469–524
  10. Spaulding SW. Hyperthyroidism (systemic effect and differential diagnosis). In:  Falk S editors. Thyroid disease (endocrinology, surgery, nuclear medicine and radiotherapy). New York: Raven Press; 1990;p. 188
  11. Van Dyke D, Anger HO, Parker H, et al.  Markedly increased bone blood flow in myelofibrosis. J Nucl Med. 1971;12:506–512
  12. Aster J, Kumar V. White cells, lymph nodes, spleen and thymus. In:  Cotran RS,  Kumar V editor. Robbins pathologic basis of disease. Philadelphia: WB Saunders; 1999;p. 684
  13. Hoffman R. Agnogenic myeloid metaplasia. In:  Hoffman R,  Benz J editor. Hematology, basic principles and practice. Philadelphia: Churchhill Livingstone; 2000;p. 1171–1188
  14. Sy WM. Bone scan in primary hyperparathyroidism. J Nucl Med. 1974;15:1089–1091
  15. Kirhnamurphy GT, Brickman AS, Blahd WH. Tc-99m pyrophosphate pharmacokinetics and bone image changes in parathyroid disease. J Nucl Med. 1977;18:236–242
  16. Sy WM, Mottola O, Lao RS, et al.  Unusual bone images in hyperparathyroidism. Br J Radiol. 1977;50:740–744
  17. Weigmann T, Rosenthall L, Kaye M. Tc-99m pyrophosphate bone scans in hyperparathyroidism. J Nucl Med. 1977;18:231–235
  18. Fogelman I, McKillop JH, Bessent RG, et al.  The role of bone scanning in osteomalacia. J Nucl Med. 1978;19:245–248
  19. Koizumi M, Matsumoto S. Distinctive patterns of super scan appearance in bone metastasis and hyperthyroidism. Clin Nucl Med. 1998;23:391–392
  20. Ryan PJ, Fogelman I. Bone scintigraphy in metabolic bone disease. Semin Nucl Med. 1997;3:291–305
  21. Fogelman I, McKiloop JH, Cowden EA, et al.  Bone scan findings in hypervitaminosis D (case report). J Nucl Med. 1977;18:1205–1207
  22. Sy WM, Bonvenite MV, Camera A. Bone scan in mastocytosis (Case report). J Nucl Med. 1976;17:699–701
  23. Constable AR, Cranage RW. Recognition of the superscan in prostate bone scintigraphy. Br J Radiol. 1981;54:122–125
  24. Witherspoon LR, Blonde L, Shuler SE, et al.  Bone scan patterns of patients with diffuse metastatic carcinoma of the axial skeleton. J Nuc Med. 1975;17: 253–25
  25. Osmond JD, Pendergrass HP, Potsaid MS. Accuracy of Tc-99m diphosphonate bone scans and roentgenogram in the detection of prostate, breast and lung carcinoma metastases. Am J Radiol. 1975;125:972–977
  26. Luina SL, Heravi M, Goel V, et al.  Pitfalls of absent or faint kidney sign on bone scan. J Nucl Med. 1980;21:894–895
  27. In:  Siegel BA editors. Nuclear Radiology (Second Series) Syllabus. Chicago: ACR; 1978;p. 411–425
  28. Manier SM, Van Nostrand D. Super bone scan. Semin Nucl Med. 1984;1:46–47
  29. Epstein DA, Alter AA, Levin EJ, et al.  Bone scintigraphy in myelofibrosis. Clin Nucl Med. 1976;1:51–55
  30. Kim EE, Deland FH. Myelofibrosis presenting as hypermetabolic bone disease by radionuclide imaging in a patient with asplenia. Clin Nucl Med. 1978;3:406–408

PII: S0001-2998(03)00107-7

doi: 10.1053/j.semnuclmed.2003.12.005

Seminars in Nuclear Medicine
Volume 34, Issue 2 , Pages 154-156 , April 2004

Article Tools

* Image Usage & Resolution